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Abstract
OBJECTIVE—Determine normal T1 and extracellular volume (ECV) of the pancreas in subjects 
with no pancreas disease and correlate with age and gender
SUBJECTS AND METHODS—We imaged 120 healthy subjects (age range: 20-78 years) who 
are on annual screening with MRI/MRCP for the possibility of pancreatic cancer. Subjects had a 
predisposition to develop pancreatic cancer, but no history of pancreas disease or acute symptoms. 
Equal number (n=60) of subjects were scanned on either 1.5 T or 3 T scanner using dual flip angle 
spoiled gradient echo technique incorporating fat suppression and correction for B1 field 
inhomogeneity. Optimization of imaging parameters were performed using a T1 phantom. ECV 
was calculated using pre- and post-contrast T1 of the pancreas and plasma. Regression analysis 
and Mann-Whitney tests were used for statistical analysis.
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RESULTS—Median T1 on 1.5 T was 654 ms (IQR: 608-700); median T1 on 3 T was 717 ms 
(IQR: 582-850); median ECV on 1.5 T was 0.28 (IQR: 0.21-0.33) and median ECV on 3 T was 
0.25 (IQR: 0.19-0.28). Age had a mild positive correlation with T1 (r= 0.24, p= 0.009), but not 
with ECV (r= 0.06, p=0.54). T1 and ECV were similar in both genders (p >0.05).
CONCLUSION—This study measured the median T1 and ECV of the pancreas in subjects with 
no pancreas disease. Pancreas shows longer T1 relaxation times in older population, whereas 
extracellular fraction remains unchanged. Median T1 values were different between two magnet 
strengths; however, no difference was seen between genders and ECV fractions.
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INTRODUCTION
Quantitative MRI is becoming increasingly common in current radiology research and 
practice, assisting in the clinical assessment of many patients with a spectrum of diseases 
[1]. Novel quantitative MR imaging techniques provide in vivo characterization of tissues 
and has potential to be a non-invasive biomarker to diagnose certain solid organ pathologies. 
Quantitative imaging metrics can also be used to monitor the course of therapy in clinical 
trials [2]. T1 relaxometry measures the specific T1 relaxation time of a tissue. A number of 
quantitative MRI studies have been published reporting the alterations of T1 in a variety of 
pathologic conditions in the abdomen [3–5]. These studies focused on detecting tissue 
fibrosis; seen with cirrhosis [6–8], chronic pancreatitis [9] and kidney failure [10]. T1 
measured during pre and post-contrast phase are used to calculate the extracellular volume 
(ECV). ECV imaging calculates the extracellular fraction of a solid organ, which is known 
to increase as a result of adverse tissue remodeling leading to tissue fibrosis [4,5]. It has 
been shown to be useful for evaluation of myocardial fibrosis [11,12], cirrhosis [8,4] and 
chronic pancreatitis [5]. However, there is insufficient data on normal quantitative metrics of 
the pancreas and correlation with biometric parameters (e.g., age and sex). More 
investigations are needed to determine the normal values and reach a consensus on the 
amount of change that should be considered clinically significant pathology. The purpose of 
this study was to determine normal T1 and ECV of the pancreas in subjects with no pancreas 
disease and correlate these quantitative metrics with age and gender.
SUBJECTS and METHODS
Subjects
This study was compliant with the Health Insurance Portability and Accountability Act and 
waiver of informed consent was obtained from the Institutional Review Board. We 
prospectively imaged 120 non-consecutive subjects between June 2016 and December 2018. 
The subjects were enrolled in the pancreatic cancer screening program and were being 
screened annually for pancreatic cancer with magnetic resonance cholangiopancreatography 
(MRCP). The purpose of this screening program is to do surveillance on subjects with a 
family history of pancreatic cancer or was found to have a genetic predisposition (e.g., 
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positive BRCA) to develop pancreatic cancer, but otherwise were healthy individuals. All 
subjects were screened with serum amylase, lipase, AST, alkaline phosphatase, CEA, 
CA19-9, and c-peptide levels before enrolling into the program. MRCP images of all the 
subjects were reviewed by a single radiologist and only those with Cambridge grade 0 
(normal) [13] were included in the study. Subjects who did not receive intravenous contrast 
(n=17), diagnosed with cystic pancreatic neoplasm (n=11) or pancreatic adenocarcinoma 
(n=1) were also excluded from the study.
T1 imaging
T1 maps were acquired at pre-contrast and 6-minute late enhancement phases using a dual 
flip angle three-dimensional (3D) spoiled gradient echo technique (Figure 1). Subjects were 
imaged on either 1.5 T (Magnetom Avanto Fit, Siemens Medical Solutions, Malvern, PA) or 
3 T scanner (Magnetom Verio, Siemens Medical Solutions, Malvern, PA) using a 
commercially available T1 mapping pulse sequence (MapIt, Siemens Medical Solutions, 
Malvern, PA). Fat suppression was not utilized. Vendor supplied correction for B1 field 
inhomogeneity was employed. The imaging parameters were; 48 axial slices of 4 mm 
thickness, field of view of 360, acquisition matrix of 320 ×168 and parallel imaging factor of 
2 (Siemens GRAPPA). The 1.5 T scanner used TR of 7.4 ms, TE of 2.39 ms, flip angles of 
3° and 19°, while the 3 T scanner used TR of 3.87 ms, TE of 1.32 ms and flip angles of 2° 
and 13°. Acquisition time was approximately 20 sec (1 breath hold). T1 maps were 
reconstructed on the MR scanner using vendor supplied software. To ensure accurate 
measurements of the T1, phantom testing was performed using a commercially available 
unit (System phantom model 130, High Precision Device, Inc.,). This phantom includes an 
array of elements of which T1 values were verified by the National Institute of Standards and 
Technology (NIST). The phantom tests showed excellent precision for both 1.5 T (ρc = 
0.9962) and 3 T scanners (ρc = 0.9974).
ECV imaging
Gadobenate dimeglumine (MultiHance, Bracco Diagnostics Inc., Monroe Township, NJ) 
was administered in all subjects using the manufacturer recommended dose of 0.1 mmol/kg. 
T1 relaxation time was measured by a single radiologist in pre and post-contrast phases, 
using average of the region of interest values obtained from the head, body, and tail of the 
pancreas. Attention was given to obtain the signal from the homogenous part of the gland, 
excluding the duct and vessels. The approximate diameter of the circle region of interest was 
15 mm. Blood pool signal was obtained from the aortic lumen to find out the plasma T1 
relaxivity. The aortic lumen signal is prone to inflow artifact and therefore, T1 was measured 
from the aortic lumen by taking the average ROI value of 5 consecutive image slices below 
the level of pancreas. These values were entered into this formula to calculate ECV fraction:
ECV = (1 − hematocrit) × Δ R1 targetΔ R1 blood
where ΔR1target and ΔR1blood are defined as the change of 1/T1 relaxation rate in pancreas 
and blood pool relaxivity before and after contrast administration. T1 is a time constant 
describing the longitudinal relaxation rate, and its reciprocal (1/T1) is referred to as R1. The 
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change in R1 (ΔR1) is defined as: ΔR1 = (R1 post-contrast) – (R1 pre-contrast). ΔR1 is 
proportional to Gadolinium (Gd) concentration when both tissues are in equilibrium; ΔR1 
pancreas / ΔR1 blood = [Gd]pancreas / [Gd]blood. Since the gadolinium chelates, such as Gd-
BOPTA are extracellular agents, the ratio of contrast agent concentrations between pancreas 
and blood equals the ratio of extracellular volume between the tissues: [Gd]pancreas / 
[Gd]blood = ECVpancreas / ECVblood. The ECV of the blood is defined as the fraction of the 
blood volume which is not composed of blood cells, in other words, the fraction composed 
of plasma. The plasma volume was easily calculated as: ECVblood = [1 – hematocrit], ECV 
maps were generated offline, using a prototype software (MR Arithmetics; Siemens 
Healthcare) (Figure 2). Non-rigid registration was also performed using this software 
between the pre- and post-contrast T1 maps to eliminate misregistration due to differences in 
breath hold.
MRCP imaging
Secretin enhanced MRCP was performed following intravenous administration of 16 μg of 
secretin (ChiRhoStim, ChiRhoClin Inc., Burtonsville, MD) via slow infusion over one 
minute. Immediately following injection, the pancreas was imaged using a coronal 2D 
single-shot turbo spin echo sequence (HASTE, Siemens Medical Solutions, Malvern, PA), 
which is repeated every 20 seconds up to 8 minutes. No adverse events were encountered.
Statistical analysis
Regression analysis was used to evaluate the correlation of the T1 and ECV with the age. 
Correlation coefficients were interpreted as; mild, 0.2; moderate, 0.5; strong, 0.8; and perfect 
1.0 [14], Mann-Whitney test was used to determine the median and interquartile range (IQR) 
at different age groups for the T1 and ECV, also for assessing the differences between the 
gender, 1.5 T and 3 T magnet strengths. If the resulting P value is <0.05, a statistically 
significant difference between the two samples was accepted. The precision of the T1 
imaging technique was evaluated using the concordance correlation coefficient. The 
concordance correlation coefficient quantifies the agreement between two measures such 
that when they are plotted against each other, higher concordance correlation coefficient 
corresponds to a lesser deviation from the 45-degree line. The scale of concordance 
correlation coefficient (ρc) is considered as poor <0.90; moderate 0.90-0.95; substantial 
0.95-0.99 and almost perfect >0.99 [15]. Statistical analyses were performed using MedCalc 
version 18.11.3 (MedCalc Software, Mariakerke, Belgium).
RESULTS
Subjects were between 20-78 years of age (mean: 48). There were 32 males and 88 females. 
Table 1 shows that there was no difference between two genders in terms of age of subjects 
scanned at 1.5 T (p=0.77) and 3 T (p=0.84); ECV at 1.5 T (p= 0.09) and 3 T (p=0.55) and T1 
at 1.5 T (p= 0.47) and 3 T (p= 0.09). Therefore, results from both genders were combined in 
the analysis.
Table 2 lists T1 measured at 1.5 T and 3 T scanners. Median T1 at 1.5 T was 654 ms (IQR: 
608-700) and was statistically different than Ti of 717 ms (IQR: 582-850) measured at 3 T 
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(p=0.03). Table 3 lists the median ECV calculated at 1.5 T and 3 T scanners. Median ECV at 
1.5 T was 0.28 (IQR: 0.21-0.33) and was similar to ECV of 0.25 (IQR: 0.19-0.28) at 3 T 
(p=0.06).
T1 relaxation time had a mild positive correlation with age (r= 0.24 p= 0.009) (Figure 3). 
ECV did not have a correlation with age (r= 0.06, p=0.54).
DISCUSSION
T1 relaxometry and ECV may provide useful applications in the abdominal imaging 
however more investigations are needed to explore the full potential. The primary objective 
of this study was to determine the normal T1 and ECV of the pancreas in subjects with no 
pancreas disease. We expect that this information can be used as a reference in future 
studies. Secondary objectives were to determine whether T1 and ECV change with age, 
gender or MR signal strength. To our knowledge, none of this information was previously 
reported in the radiology literature.
Our first observation was that the median T1 of the pancreas were different between 1.5 T 
and 3 T scanners when all age groups were combined. It is well known that the longitudinal 
relaxation time (T1), is longer at higher magnetic field than at lower magnetic field [16,17] 
therefore different threshold values should be used for different magnet strengths. As the 
main B0 field strength increases, the resonance frequency of the excited spins also increases 
(from approximately 64 MHz at 1.5 T to 128 MHz at 3 T) [18]. The higher frequency of the 
spins reduces the efficiency of energy transfer, resulting in longer T1 relaxation times at 3 T 
[19]. We found that ECV fractions at 1.5 and 3 T to be similar.
Our second significant finding was that age had a mild positive correlation with T1. Many 
studies reported correlation of T1 signal intensity of the pancreas with fibrosis (determined 
by histopathology), bicarbonate level measured via endoscopic pancreatic function tests, or 
evidence of chronic pancreatitis determined by Cambridge classification [20–23]. This is the 
first study showing that pancreas is slowly losing its shorter T1 relaxation property over the 
period of decades. On the other hand, ECV remained the same over a wide range of subjects 
age (20 – 78 years), indicating that extracellular to intracellular ratio is not altered in 
subjects with no pancreas disease.
Our third finding was that, both genders had similar ECV fraction and T1. Therefore, we 
combined both genders in the analysis.
We used a commercially available T1 mapping pulse sequence which utilizes 3D dual flip 
angle spoiled gradient echo technique to acquire T1 maps of the entire upper abdomen in one 
breath-hold. Currently, there is no consensus about which T1 mapping pulse sequence is 
ideal for abdominal imaging. Conventional Look-Locker T1 mapping sequences require long 
imaging times [24] and will be challenging for abdominal imaging which large spatial 
coverage is essential. Efforts have been made to modify the Look-Locker method [25] by 
combining it with a stack-of-spirals acquisition accelerated using 3D through-time spiral 
GRAPPA reconstruction; producing 32 images per breath hold. These new methods require 
more studies for validation and support from vendors. Recently, a novel approach named 
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MR fingerprinting was introduced [26]. Instead of using a repeated, serial acquisition of data 
for the characterization of individual parameters of interest, MR fingerprinting uses a 
pseudorandomized acquisition that causes the signals from different tissues to have a unique 
signal evolution or ‘fingerprint’ that is simultaneously a function of the multiple material 
properties. The processing after acquisition involves a pattern recognition algorithm to 
match the fingerprints to a predefined dictionary of predicted signal evolutions. A recent MR 
fingerprinting study on 14 asymptomatic subjects reported T1 of the liver, kidney, spleen, 
skeletal muscle and fat [27] but did not report T1 of the pancreas.
ECV imaging can distinguish intra- and extracellular spaces of the tissues and calculates the 
fraction of the extracellular volume. ECV imaging is based on the concept that extracellular 
matrix increases when tissues are subjected to repetitive inflammation leading tissue 
remodeling and eventually fibrosis. MRI is an ideal modality to calculate ECV since the 
gadolinium diffuses from the intravascular to the extracellular space of the tissues. ECV is 
calculated by measuring the T1 of the plasma and the target tissue before and after contrast 
injection. We used the aortic lumen to determine the blood plasma relaxivity since it has a 
larger diameter than other vessels and has been successfully used in prior studies [5,28]. It 
should be noted that the dual flip angle sequence is susceptible to pulsatile flow in the aorta. 
Other pulse sequences with cardiac gating produce more stable aortic signal; however the 
downside is acquisition of only 1-3 images per breath hold.
One of the limitations of this study was that the population of 120 subjects became small 
when divided by 6 age groups, especially in the age 70-78 group. The subjects were 
predominantly females however, results showed that gender difference did not effect T1 and 
ECV. Our study included subjects with a genetic predisposition for pancreatic cancer, 
however, had no known pancreatic disease or symptoms at the time of the study. We further 
screened the subjects with secretin enhanced MRCP and included only those with 
Cambridge grade 0. Nevertheless, when determining the normal quantitative MR metrics, it 
would be ideal to image healthy volunteers at multiple institutions by comparing different 
MR vendors and imaging techniques.
In conclusion, this study measured the median T1 and ECV of the pancreas in subjects with 
no pancreas disease. Pancreas shows longer T1 relaxation times in older population, whereas 
extracellular fraction remains unchanged. No difference was seen between genders. Separate 
T1 values should be used for 1.5 and 3 T scanners.
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This is an axial T1 map in a 51-year-old man with family history of pancreatic cancer on 
surveillance. T1 maps can be depicted either as a grayscale or colormap. Region of interest 
measurements obtained from the grayscale image reveals the T1 relaxation time (P: 
pancreas, S: spleen).
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ECV map of the pancreas. This is a 37-year-old woman with BRCA 2 gene mutation on 
surveillance for pancreatic cancer. An axial color scale ECV map is shown. (P: pancreas, S: 
spleen, L: liver)
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Effect of age on T1 properties of the pancreas. There is a mild positive correlation between 
T1 relaxation time and age (r= 0.24 p= 0.009).
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Table 1.
Effect of gender and MR field strength on T1 relaxation time (ms) and ECV of the pancreas. There was no 
statistically significant difference between two genders in terms of T1, ECV and age.
Male n=32 Female n=88
Median IQR Median IQR P value
T1 (ms) 1.5 T 659 [571-707] 649 [609-696] 0.47
3.0 T 636 [551-712] 753 [637-871] 0.09
ECV (fraction) 1.5 T 0.25 [0.17-0.32] 0.29 [0.24-0.34] 0.09
3.0 T 0.24 [0.20-0.26] 0.25 [0.19-0.29] 0.55
Age (years) 1.5 T 48 [37-59] 48 [37-58] 0.77
3.0 T 52 [43-58] 52 [43-59] 0.84
ECV: Extracellular volume fraction. IQR=Interquartile range
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Table 2.
T1 relaxation time of the pancreas at 1.5 T and 3 T magnet field strength separated by age groups. There was a 
significant difference in T1 between the 1.5 and 3 T when all age groups were combined (p=0.03).
T1
Age Groups 1.5 Tesla n 3 Tesla n
All ages 654 ms [608-700] 60 717 ms [582-850] 60
Age 20-29 678 ms [575-763] 9 642 ms [533-712] 5
Age 30-39 645 ms [609-735] 12 653 ms [428-772] 11
Age 40-49 655 ms [637-697] 12 734 ms [600-859] 11
Age 50-59 608 ms [557-690] 15 753 ms [640-885] 19
Age 60-69 671 ms [628-697] 10 762 ms [576-965] 10
Age 70-79 645 ms [610-680] 2 807 ms [714-984] 4
Numbers in bracket indicate interquartile range (IQR).
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Table 3.
ECV of the pancreas at 1.5 and 3 T scanners separated by age groups. There was no significant difference in 
median ECV between the two magnet strengths when all age groups were combined (p=0.06).
ECV fraction
Age Groups 1.5 Tesla n 3 Tesla n
All Ages 0.28 [0.21-0.33] 60 0.24 [0.19-0.28] 60
Age 20-29 0.34 [0.30-0.39] 9 0.25 [0.22-0.26] 5
Age 30-39 0.25 [0.19-0.29] 12 0.19 [0.14-0.23] 11
Age 40-49 025 [0.20-0.33] 12 0.24 [0.19-0.33] 11
Age 50-59 0.31 [0.22-0.36] 15 0.26 [0.22-0.27] 19
Age 60-69 0.27 [0.22-0.28] 10 0.27 [0.22-0.32] 10
Age 70-79 0.23 [0.23-0.23] 2 0.27 [0.23-0.34] 4
ECV: Extracellular volume fraction. Numbers in bracket indicate interquartile range (IQR).
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